Literature DB >> 3667376

5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous cell carcinoma.

M J Weinberg1, A M Rauth.   

Abstract

The present investigation describes the effects on a murine squamous cell tumor of combined treatment using radiation and 5-Fluorouracil (5FU), with emphasis on 5FU infusions. The tumor, SCC VII/To, was grown intramuscularly in the hind legs of C3H mice. Radiation was given locally with 100 kVp X rays either alone or in combination with 5FU by i.p. bolus injections or 4-14 day infusions using subcutaneously implanted mini-osmotic pumps. Studies with radiation alone indicated regrowth delay increased with total dose. This increase was less for fractionated than single doses. The effects of 5FU alone were compared using i.p. injections or 4, 7 or 14 day infusions. Tumor response to single i.p. bolus injections or 4 day infusions were not significantly different. Up to total drug doses of 200 mg/kg, 14 day infusions were least effective on regrowth delay, 4 day infusions were intermediate and 7 day infusions were most effective. Above total drug doses of 200 mg/kg, effects of 14 day infusions on regrowth delay increased rapidly. The LD50 for single i.p. bolus injections and 7 day infusions were similar, 230 and a total drug dose of 270 mg/kg, respectively. When a 7 day infusion of 5FU (133 mg/kg) was combined with increasing total radiation doses (1 or 5 fractions), the increase in regrowth delay was additive. Combining a fractionated dose of 5 Gy per day for 5 days (5/5 Gy) with increasing total drug doses of 5FU (single i.p. bolus injections or 4, 7 or 14 day infusions) resulted in regrowth delays that were dependent on the total dose of 5FU. Administering a 133 mg/kg dose of 5FU (via a single i.p. bolus injection or 7 day infusion) starting 2 days before, during, or immediately after 5/5 Gy gave the same regrowth delay, indicating no effect of drug sequencing. In conclusion, the above data indicate that (a) 5FU infusions (greater than 4 days) are more effective than 5FU injections on regrowth delay and (b) combinations of 5FU and radiation, produce an additive tumor response, which occurs independent of mode, schedule, and time of 5FU administration, and is dependent on 5FU total dose.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667376     DOI: 10.1016/0360-3016(87)90166-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  The combined antitumour effect of a new 5-fluorouracil derivative, BOF-A2, and radiation in vivo.

Authors:  R Murata; Y Shibamoto; S Miyauchi; M Hirohashi; T Takagi; K Sasai; N Oya; M Hiraoka
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Radiation sensitivity of tumour cells stained in vitro or in vivo with the bisbenzimide fluorochrome Hoechst 33342.

Authors:  S D Young; R P Hill
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

3.  Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours.

Authors:  Y Shibamoto; R Murata; S Miyauchi; M Hirohashi; T Takagi; K Sasai; T Shibata; N Oya; M Takahashi
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

4.  Phase II study of concurrent capecitabine and external beam radiotherapy for pain control of bone metastases of breast cancer origin.

Authors:  Yulia Kundel; Nicola J Nasser; Ofer Purim; Rinat Yerushalmi; Eyal Fenig; Raphael M Pfeffer; Salomon M Stemmer; Shulamith Rizel; Zvi Symon; Bella Kaufman; Aaron Sulkes; Baruch Brenner
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

5.  Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.

Authors:  T Ishikawa; Y Tanaka; H Ishitsuka; T Ohkawa
Journal:  Jpn J Cancer Res       Date:  1989-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.